Fisher Wallace Laboratories, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-13.
Fisher Wallace Laboratories, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 13, 2025. Its industry group is Biotechnology. It names Kelly Roman (Executive Officer, Director), Charles Fisher (Director) (SEC Form D, June 13, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Fisher Wallace Laboratories, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Fisher Wallace Laboratories, Inc.
Free to see. No signup.
More on the people and the money behind Fisher Wallace Laboratories, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Fisher Wallace Laboratories, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Fisher Wallace Laboratories, Inc. raises, hires or launches. No email unless you switch it on.
Watch Fisher Wallace Laboratories, Inc. →Get the full cited report on Fisher Wallace Laboratories, Inc.
What the filing shows about Fisher Wallace Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Fisher Wallace Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Fisher Wallace Laboratories, Inc.'s address as 630 Flushing Avenue, Box 104, Brooklyn, NY 11206.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Fisher Wallace Laboratories, Inc. See pricing
Fisher Wallace Laboratories, Inc. is a registered filer with the SEC (CIK 1787792) and has filed since 2025-06-13. 1 filing is on record, the latest on 2025-06-13.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Fisher Wallace Laboratories, Inc.'s Form D of 2025-06-13 names Kelly Roman and Charles Fisher as its officers, directors or promoters.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Kelly Roman is named as Executive Officer and Director on the Form D that Fisher Wallace Laboratories, Inc. filed with the SEC on 13 June 2025, one of 2 people that filing names.
Charles Fisher is named as Director on the Form D that Fisher Wallace Laboratories, Inc. filed with the SEC on 13 June 2025, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2025-06-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Fisher Wallace Laboratories, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Fisher Wallace Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fisher Wallace Laboratories, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Fisher Wallace Laboratories, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Fisher Wallace Laboratories, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Fisher Wallace Laboratories, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in New York
https://mentionfox.com/funding/fisher-wallace-laboratories-inc-form-d-25000001